ESR1 and breast cancer: In particular, the expression of arginine and glutamate rich 1, a MED1-interacting protein required for estrogen-dependent gene transcription and breast cancer cell growth [21], was 4.9-fold higher in ER-negative tumors than ER-positive tumors (p < 0.001, FDR p = 0.0267).